Literature DB >> 21075083

Effects of perinatal cocaine exposure on open field behavior and the response to corticotropin releasing hormone (CRH) in rat offspring.

Thitinart Sithisarn1, Henrietta S Bada, Hongying Dai, David C Randall, Sandra J Legan.   

Abstract

Previous reports indicate that prenatal cocaine exposure alters specific behaviors and hypothalamic-pituitary-adrenal axis (HPA) function in the offspring. In most previous studies, cocaine was given via subcutaneous injections. However intravenous administration more closely mimics human cocaine abuse during pregnancy. Therefore, we investigated the effects of prenatal cocaine exposure via intravenous injection to the mothers on open field behavior and HPA axis function of the offspring. We hypothesized that prenatal cocaine exposure decreases immobility in a novel environment, and enhances the HPA response to stress. Dams received cocaine (COC) or vehicle (control, CON) intravenously from gestation day 8 to postnatal day (PD) 5. Behaviors were recorded in the open field on PD 28 (weanlings). As expected, perinatally cocaine-exposed offspring spent less time immobile and had a longer latency to entering the center zone. No other behavioral activities were different between the groups. On PD 43-50, adolescent male and female offspring received either corticotropin releasing hormone (CRH) or saline intravenously. Plasma adrenocorticotropic hormone (ACTH) and corticosterone (CORT) levels were determined before, and up to 60 min after injection. COC-exposed offspring of both sexes had higher basal CORT levels. Prenatal cocaine enhanced the CORT response to CRH/saline injections up to 60 min in males but not in females. These novel results show that perinatal administration of cocaine in a manner that most closely mimics human cocaine use has long-term effects on the offspring's behavioral response to stress and on HPA axis functions. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21075083     DOI: 10.1016/j.brainres.2010.11.024

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Enhanced anxiety in the male offspring of sires that self-administered cocaine.

Authors:  Samantha L White; Fair M Vassoler; Heath D Schmidt; R Christopher Pierce; Mathieu E Wimmer
Journal:  Addict Biol       Date:  2015-04-29       Impact factor: 4.280

Review 2.  Cocaine-induced neurodevelopmental deficits and underlying mechanisms.

Authors:  Melissa M Martin; Devon L Graham; Deirdre M McCarthy; Pradeep G Bhide; Gregg D Stanwood
Journal:  Birth Defects Res C Embryo Today       Date:  2016-06

3.  Substance Use among Adolescent Mothers: A Review.

Authors:  Shawna L Carroll Chapman; Li-Tzy Wu
Journal:  Child Youth Serv Rev       Date:  2013-05-01

4.  Paternal morphine self-administration produces object recognition memory deficits in female, but not male offspring.

Authors:  Alexandra S Ellis; Andre B Toussaint; Melissa C Knouse; Arthur S Thomas; Angela R Bongiovanni; Hannah L Mayberry; Shivam Bhakta; Kyle Peer; Debra A Bangasser; Mathieu E Wimmer
Journal:  Psychopharmacology (Berl)       Date:  2020-01-07       Impact factor: 4.530

5.  The GNE-KLH anti-cocaine vaccine protects dams and offspring from cocaine-induced effects during the prenatal and lactating periods.

Authors:  Paulo Sérgio de Almeida Augusto; Raissa Lima Gonçalves Pereira; Sordaini Maria Caligiorne; Brian Sabato; Bruna Rodrigues Dias Assis; Larissa Pires do Espírito Santo; Karine Dias Dos Reis; Gisele Assis Castro Goulart; Ângelo de Fátima; Maila de Castro Lourenço das Neves; Frederico Duarte Garcia
Journal:  Mol Psychiatry       Date:  2021-08-11       Impact factor: 15.992

6.  Early life adversity as a risk factor for fibromyalgia in later life.

Authors:  Lucie A Low; Petra Schweinhardt
Journal:  Pain Res Treat       Date:  2011-10-12

Review 7.  Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling.

Authors:  Alexis L Franks; Kimberly J Berry; Donald B DeFranco
Journal:  J Neuroendocrinol       Date:  2019-10-02       Impact factor: 3.870

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.